# RNN 1st Gen Model Cardinal Health, Inc. Drugs, proprietaries, & sundries
at 17-jan-2020
CAH
Model's trade recommendations 2.64% Return for period
-10.86% Annual return
$20.35B Market Cap
β 1.06
CAH
Model (following trade recommendations)CAH
Underlying stockS&P 500
Index- 1.85 (2.86%) Div (Yield)
- HOLD Analysts consensus recommendation
Cardinal Health, Inc. is a global, integrated healthcare services and products company, providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices worldwide. The company provides clinically proven medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency from hospital to home. Cardinal Health connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination and better patient management.
Industry sector: Medical
Sector classification: Drugs, proprietaries, & sundries
Deep Learning based analysis and prediction model for Cardinal Health, Inc. (CAH) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.
Model is in the production pipeline since Oct. 2, 2015.
Market data for CAH model training are being downloaded from the Quandl premium datasets on a daily basis.
Model is being retrained on a daily basis.
| Float | 312M |
| P/E | 12.34 |
| Shares Outstanding | 315M |
| % Held by Insiders | 0.97% |
| % Held by Institutions | 89.95% |
| EPS (last reported FY) | $5.40 |
| EPS (last reported Q) | $1.31 |
| EPS, estimated (last reported Q) | $1.14 |
| Total revenues | $130 B |
| Net income | $1 B |